Is LFST Worth Buying in 2026?

LifeStance Health Group, Inc. Common Stock

STOCK SERVICES-HEALTH SERVICES Updated 2026-05-24

Here’s whether LifeStance Health Group, Inc. Common Stock (LFST) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.29% over 10 days); RSI 51 — healthy momentum range; strong 1-year return of +31.3%. Currently 16.9% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

LFST is in a confirmed uptrend, trading above both its 50-day ($7.00) and 200-day ($6.39) moving averages. An RSI of 51.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +31.3% compares to +27.9% for SPY (beat the market by 3.4%).

$10,000 invested 1 year ago → $13,126 today
vs. S&P 500 (SPY) — same period beat market by 3.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($6.39)
Above 50-day MA ($7.00)
RSI(14) neutral zone (30–70) — currently 51.4
Positive return (+31.3%)
!Within 10% of period high (−16.9%)
Period Range $7.39
$3.74 $8.89
RSI (14) 51.4
0 · OversoldOverbought · 100

Key Metrics

Price$7.39
Period Return+31.3%
Period High$8.89
Period Low$3.74
Drawdown−16.9%
MA-50$7.00
MA-200$6.39
RSI (14)51.4
Avg Volume (30d)5.8M
vs. SPYbeat by 3.4%
Return Rank#483 of 1236

Trade LFST

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers